Carolina Trust Bank Stock News

Instacart and the U.S. Department of Health and Human Services (HHS) are teaming up to help more people access healthy food and tools for better health.   The partnership's goal is to back and exten

Instacart has significantly expanded its acceptance of Supplemental Nutrition Assistance Program (SNAP) Electronic Benefits Transfer (EBT) payments, as aggregators compete to unlock the spending oppor

Up 2.1% year-to-date, the group has a sizable early lead over its roughly flat sector. Over the last 10 years, the staples distribution and retail industry have had a 134% cumulative return compared

SAN FRANCISCO , Jan. 23, 2024 /PRNewswire/ -- Instacart (NASDAQ: CART) today announced it will report its fourth quarter and full year 2023 financial results after market close on Tuesday, February 1

Benchmark analyst Mark Zgutowicz initiated coverage of groceries-delivery firm Instacart with a Buy rating and $32 price target.

Instacart shares have been under pressure since the company joined the public market.

Instacart (NASDAQ: CART) has been in a downtrend ever since it debuted on Nasdaq but a Wolfe Research analyst is confident the stock will rebound in 2024.

Instacart and DoorDash are raising prices in Seattle following the city's new minimum pay law. Seattle in 2022 passed legislation that increased wages for drivers for the delivery apps.

The fortunes of gig-economy giants like Uber Technologies Inc., DoorDash Inc. and Instacart will increasingly depend on their ability to broaden what they deliver and to integrate more deeply into loc

With grocery brands looking for more personalized, targeted ways to reach shoppers, Instacart is enabling in-store digital marketing with smart cart advertising. The grocery aggregator announced Monda

Instacart will show advertisements on the high-tech shopping carts it sells to grocery stores, the latest addition to the company's growing ads business and a sign of investment in products outside gr

Among 2023 IPOs, one of the top performers was RayzeBio Inc. NASDAQ: RYZB, a biotech that's out of play now because it's being acquired by Bristol Myers Squibb Co. NYSE: BMY.

The U.S. market for initial public offerings is expected to stage a recovery in 2024 from the drought of the last two years, buoyed by expectations the Federal Reserve will switch to a rate-cutting cy

The U.S. economy is poised for a positive trajectory in 2024, marked by the first price decline in over 3-1/2 years and an annual inflation rate below 3%. The resilient labor market, decreasing inflat

After navigating treacherous waters in the preceding year, the US initial public offering (IPO) market embarked on a path of recovery in 2023, signaling the inception of a new upcycle.